0001415889-16-005150.txt : 20160317 0001415889-16-005150.hdr.sgml : 20160317 20160317180918 ACCESSION NUMBER: 0001415889-16-005150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160315 FILED AS OF DATE: 20160317 DATE AS OF CHANGE: 20160317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stankovic Srdjan R. CENTRAL INDEX KEY: 0001432545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 161513559 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 form4-03172016_030311.xml X0306 4 2016-03-15 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001432545 Stankovic Srdjan R. 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 false true false false EVP Stock Option (right to buy) 19.65 2016-03-15 4 A 0 150000 0 A 2026-03-14 Common Stock 150000 150000 D 25% of the shares subject to the Stock Option vest and become exercisable on March 15, 2017. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Elizabeth Carter, Attorney-in-Fact 2016-03-17 EX-24 2 ex24-03172016_030311.htm POWER OF ATTORNEY

POWER OF ATTORNEY



Know all by these presents, that the undersigned hereby authorizes Glenn F. Baity, Elizabeth Carter, Martin Choy and/or Eric Miller to execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer of ACADIA Pharmaceuticals Inc. (the “Company”), Forms 3, 4 and 5 and any Amendments thereto, and cause such form(s) to be filed with the Securities and Exchange Commission pursuant to Section 16(a) of the Securities Exchange Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company.  The undersigned hereby grants to such attorneys-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or substitute or substitutes of such attorneys-in-fact, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that each foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.


This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 10, 2016.




/s/ Srdjan Stankovic

Srdjan Stankovic, M.D., M.S.P.H.